Pang Wenbo,Chen Yajun,Zhang Tingchong,et al.Diagnosis,management and prognosis of post-Kasai cholangitis[J].Journal of Clinical Pediatric Surgery,2022,21(01):41-45.[doi:10.3760/cma.j.cn.101785-202006073-008]
胆道闭锁Kasai术后胆管炎的诊治及预后研究
- Title:
- Diagnosis,management and prognosis of post-Kasai cholangitis
- Keywords:
- Biliary Atresia/SU; Cholangitis/DI; Cholangitis/TH; Prognosis
- 摘要:
- 目的 总结胆道闭锁Kasai术后胆管炎的诊治经验，并分析其长期预后。方法 采用回顾性研究方法，收集2008年6月至2017年6月首都医科大学附属北京儿童医院普外科收治的66例胆道闭锁Kasai手术后胆管炎患儿临床资料，根据初次胆管炎发作时初始治疗用药情况分为头孢哌酮舒巴坦组（17例）、美罗培南组（12例）以及亚胺培南西司他丁钠组（37例），根据治疗后有无复发分为复发组（15例）、无复发组（51例）。按照不同分组方法进行疗效（初次胆管炎疗效）及远期预后（胆管炎治愈率和5年自体肝生存率）的评估与比较。结果 头孢哌酮舒巴坦组、美罗培南组和亚胺培南西司他丁钠组三组胆管炎患儿经初始用药治疗后有效率分别为41.2%、75.0%和89.2%，差异有统计学意义（χ2=14.046，P=0.001），两两比较结果显示，亚胺培南西司他丁钠组有效率明显高于头孢哌酮舒巴坦组（89.2% vs.41.2%，χ2=13.982，P<0.001）。就远期预后而言，复发组总体治愈率较无复发组低（40.0% vs.88.2%，χ2=15.356，P<0.001），无复发组5年自体肝生存率明显优于复发组（82.8% vs.41.5%，χ2=7.993，P=0.005）。结论 早期优化胆道闭锁Kasai手术后胆管炎的治疗，有利于实现患者远期自体肝生存，Kasai手术后胆管炎发作可首选亚胺培南西司他丁钠抗感染治疗，多次发作胆管炎对患者预后不利。
- Abstract:
- Objective To summarize the experience in the diagnosis and treatment of cholangitis after Kasai operation in children with biliary atresia, and analyze its longterm prognosis. Methods A retrospective study was performed on the clinical data of 66 cholangitis patients after Kasai operation from June 2008 to June 2017.The patients were categorized into Cefoperazone-Sulbactam group (n=17), Meropenem group (n=12) and Imipenem-Cilastatin Sodium group (n=37) according to the initial medication at the onset of primary cholangitis.and recurrence group (n=15) and non-recurrence group (n=51) based on the recurrence of cholangitis after treatment.The efficacy (primary cholangitis efficacy) and long-term prognosis (cure rate of cholangitis and 5-year survival rate of native liver) were compared between each group. Results The effective rates of the three initial medication groups were significantly different (41.2% vs.75.0% vs.89.2%;χ2=14.046, P=0.001), and Imipenem-Cilastatin Sodium group was obviously more effective than Cefoperazone-Sulbactam group (89.2% vs.41.2%;χ2=13.982, P<0.001).Compared with recurrence group, the non-recurrence group has higher cure rate of cholangitis in terms of long term prognosis (40.0% vs.88.2%;χ2=15.356, P<0.001)and native liver survival rate (82.8% vs.41.5%;χ2=7.993, P=0.005). Conclusion Early optimal management of post-Kasai cholangitis will help to maintain the native liver survival in the long term.Imipenem-Cilastatin Sodium can be the first choice of medication for recurrent post-Kasai cholangitis.Recurrence of cholangitis will expert adverse effects on patients’ prognosis.
参考文献/References:
[1] Nio M,Wada M,Sasaki H,et al.Risk factors affecting late-presenting liver failure in adult patients with biliary atresia[J].J Pediatr Surg,2012,47(12):2179-2183.DOI:10.1016/j.jpedsurg.2012.09.003.
[2] Liu J,Dong R,Chen G,et al.Risk factors and prognostic effects of cholangitis after Kasai procedure in biliary atresia patients:A retrospective clinical study[J].J Pediatr Surg,2019,54(12):2559-2564.DOI:10.1016/j.jpedsurg.2019.08.026.
[3] Koga H,Wada M,Nakamura H,et al.Factors influencing jaundice-free survival with the native liver in post-portoenterostomy biliary atresia patients:Results from a single institution[J].J Pediatr Surg,2013,48(12):2368-2372.DOI:10.1016/j.jpedsurg.2013.08.007.
[4] Bowles BJ,Abdul-Ghani A,Zhang J,et al.Fifteen years experience with an antirefluxing biliary drainage valve[J].J Pediatr Surg,1999,34(11):1711-1714.DOI:10.1016/s0022-3468(99)90651-6.
[5] Ogasawara Y,Yamataka A,Tsukamoto K,et al.The intussusceptions antireflux valve is ineffective for preventing cholangitis in biliary atresia:a prospective study[J].J Pediatr Surg,2003,38(12):1826-1829.DOI:10.1016/j.jpedsurg.2003.08.025.
[6] Barkin RM,Lilly JR.Biliary atresia and the Kasai operation:continuing care[J].J Pediatr,1980,96(6):1015-1019.DOI:10.1016/s0022-3476(80)80628-7.
[7] 郭鑫,孙雪,任红霞.102例胆道闭锁Kasai术后胆管炎分析[J].临床小儿外科杂志, 2017,16(2):146-150.DOI:10.3969/j.issn.1671-6353.2017.02.010. Guo X,Sun X,Ren HX.Analysis of cholangitis in patients with biliary atresia after Kasai operation[J].J Clin Ped Sur,2017,16(2):146-150.DOI:10.3969/j.issn.1671-6353.2017.02.010.
[8] 中华医学会小儿外科学分会肝胆外科学组,中国医师协会器官移植医师分会儿童器官移植学组.胆道闭锁诊断及治疗指南(2018版)[J].临床肝胆病杂志, 2019, 35(11):2435-2440.DOI:10.3969/j.issn.1001-5256.2019.11.009. Section of Hepatobiliary Surgery,Branch of Pediatric Surgery,Chinese Medical Association,Section of Pediatric Hepatic Transplantation,Branch of Organ Transplantation,Chinese Medical Doctor Association.Guidelines for diagnosing&treating biliary atresia (2018 Edition)[J].J Clin Hepatol,2019,35(11):2435-2440.DOI:10.3969/j.issn.1001-5256.2019.11.009.
[9] Luo Q,Hao F,Zhang M,et al.Serum bacterial DNA detection in patients with cholangitis after Kasai procedure[J].Pediatr Int,2015,57(5):954-960.DOI:10.1111/ped.12737.
[10] Schneider J,De Waha P,Hapfelmeier A,et al.Risk factors for increased antimicrobial resistance:a retrospective analysis of 309 acute cholangitis episodes[J].J Antimicrobl Chemother,2014,69(2):519-525.DOI:10.1093/jac/dkt373.
[11] Lee JY,Lim LT,Quak SH,et al.Cholangitis in children with biliary atresia:Health-care resource utilization[J].J Paediatr Child Health,2014,50(3):196-201.DOI:10.1111/jpc.12463.
[12] Chung PHY,Tam PKH,Wong KKY.Does the identity of the bacteria matter in post-Kasai cholangitis?A comparison between simple and intractable cholangitis[J].J Pediatr Surg,2018,53(12):2409-2411.DOI:10.1016/j.jpedsurg.2018.08.028.
[13] Bijl EJ,Bharwani KD,HouwenRH,et al.The long-term outcome of the Kasai operation in patients with biliary atresia:a systematic review[J].Neth J Med,2013,71(4):170-173.
[14] Ernest van Heurn LW,Saing H,Tan PK.Cholangitis after hepatic portoenterostomy for biliary atresia:a multivariate analysis of risk factors[J].J Pediatr,2003,142(5):566-571.DOI:10.1067/mpd.2003.195.
[15] Wang Z,Chen Y,Peng C,et al.Five-year native liver survival analysis in biliary atresia from a single large Chinese center:The death/liver transplantation hazard change and the importance of rapid early clearance of jaundice[J].J Pediatr Surg,2019,54(8):1680-1685.DOI:10.1016/j.jpedsurg.2018.09.025.
[16] 陈功,郑珊.《中国大陆地区胆道闭锁诊断及治疗(专家共识)》解读[J].中华小儿外科杂志, 2014, 35(4):311-314.DOI:10.3760/cma.j.issn.0253-3006.2014.04.017. Chen G,Zheng S.Interpretation of diagnosis and treatment of biliary atresia in Chinese mainland (expert consensus)[J].Chin J Pediatr Surg,2014,35(4):311-314.DOI:10.3760/cma.j.issn.0253-3006.2014.04.017.
相似文献/References:
[1]刘钢高昕刘树立黄柳明王伟邵培侯文英张军李龙.胆道闭锁葛西手术后肝内胆管扩张的治疗与预后分析[J].临床小儿外科杂志,2010,9(03):0.
LIU Gang,GAO Xin,LIU Shu-li,et al.The managements and prognosis of intrahepatic biliary dilatation with biliary atresia after Kasai procedure[J].Journal of Clinical Pediatric Surgery,2010,9(01):0.
[2]潘静,郑永钦,佘锦标,等.胆道闭锁术后肝内胆管囊性扩张的诊治[J].临床小儿外科杂志,2008,7(04):0.
[3]沈淳,郑珊,王玮,等.手术年龄对胆道闭锁Kasai手术后预后影响的研究[J].临床小儿外科杂志,2007,6(03):6.
[4]詹江华 管志伟 罗喜荣 包国强 刘谊 王栋. I型胆管闭锁的外科治疗[J].临床小儿外科杂志,2012,11(01):10.
[5]张金山 李龙 侯文英 刘树立. Ⅲ型胆道闭锁不同亚型与预后关系的探讨[J].临床小儿外科杂志,2012,11(04):244.
[J].Journal of Clinical Pediatric Surgery,2012,11(01):244.
[6]彭宇明,司中州,袁妙贤,等.儿童肝移植20例诊治分析[J].临床小儿外科杂志,2019,18(08):681.[doi:10.3969/j.issn.1671-6353.2019.08.013]
Peng Yuming,Si Zhongzhou,Yuan Miaoxian,et al.Diagnoses and treatments of hepatic transplantation in 20 children[J].Journal of Clinical Pediatric Surgery,2019,18(01):681.[doi:10.3969/j.issn.1671-6353.2019.08.013]
[7]李丽芳,许燕,舒仕瑜.485例胆道闭锁行Kasai手术患儿的麻醉分析[J].临床小儿外科杂志,2019,18(10):864.[doi:10.3969/j.issn.1671-6353.2019.10.013]
Li Lifang,Xu Yan,Shu Shiyu.Anesthetic analysis of 485 patients with biliary atresia during Kasai surgery[J].Journal of Clinical Pediatric Surgery,2019,18(01):864.[doi:10.3969/j.issn.1671-6353.2019.10.013]
[8]张树建,窦然,詹江华.Kasai手术中空肠胆支保留长度与胆管炎发生关系的研究进展[J].临床小儿外科杂志,2020,19(09):851.[doi:10.3969/j.issn.1671-6353.2020.09.018]
Zhang Shujian,Dou Ran,Zhan Jianghua.Research advances in the relationship between Roux-en-Y limb length during Kasai portoenterostomy and cholangitis[J].Journal of Clinical Pediatric Surgery,2020,19(01):851.[doi:10.3969/j.issn.1671-6353.2020.09.018]
[9]詹江华,陈亚军.Kasai手术与肝移植治疗胆道闭锁的利弊思考[J].临床小儿外科杂志,2021,20(02):101.[doi:10.12260/lcxewkzz.2021.02.001]
Zhan Jianghua,Chen Yajun.Advantages and disadvantages of Kasai operation and liver transplantation for biliary atresia[J].Journal of Clinical Pediatric Surgery,2021,20(01):101.[doi:10.12260/lcxewkzz.2021.02.001]
[10]吴晓霞,任红霞,靳园园,等.胆道闭锁Kasai手术后自体肝生存时间小于2年的危险因素分析[J].临床小儿外科杂志,2021,20(02):114.[doi:10.12260/lcxewkzz.2021.02.003]
Wu Xiaoxia,Ren Hongxia,Jin Yuanyuan,et al.Risk factors of native liver survival time under 2 years after Kasai operation for biliary atresia[J].Journal of Clinical Pediatric Surgery,2021,20(01):114.[doi:10.12260/lcxewkzz.2021.02.003]
备注/Memo
收稿日期:2020-06-29。
基金项目:中国工程院-外科扶持基金；北京市医院管理中心"青苗"计划专项经费资助（QML20191205）
通讯作者:陈亚军,Email:chenyajunmd@aliyun.com